Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Somebody had too much to drink last night, LOL
Where are the links to those new share claims?
Cannabis Stocks starting to RUN, one up 146% on 100M traded!!
Looks like the old days, we are starting to see some HUGE moves in micro cap cannabis stocks.
Let's see if the up trend continues.
Closed up 146% on 105 Million Shares LOL
PVSP is worth 10 times what GGII is and yet it takes off on some related Snoop Dog release.
GGII like PVSP up 107% today on 47M Shares
.0034 per share latest
These are the guys with 18 Billion Shares and $5 M annual revenue with a bunch of debt and stock explodes on PR congratulations to Snoop Dog for signing a deal with Hepacco, LOL
Go figure, the pinks are just NUTS is. all I can say
Price should be at 1/2 to 1 Penny, $25M to $50M Market Cap
We are at $3 Million, LOL
More like anytime after March/April
Management tweet says they now expect the Audited Financials to be completed by end of March or early April.
Once complete, a Form 10 Registration Statement will be filed with the SEC for Artizen to initiate the spin-off process. Additional information regarding the status and timing of the transaction and the various required regulatory and other approvals will be provided as it becomes available. Pervasip has commenced evaluation of potential targets for acquisition upon completion of the Artizen spin-off.
"Twitter $PVSP ... PLUS we cleared a million dollars of debt as part of the acquisition, cleaned up and created a functional finance and accounting structures, and by end of March/early April Pervasip will also have audited financials. Cleaner, stronger, and ready for more!"
Long-awaited Md. cannabis bill lands, sponsored in House by two skeptics
More and more pressure to make cannabis legal, 2023 will be banner year!!
William F. Zorzi
February 4, 2023, 5:24 AM
The two lawmakers who are cosponsoring the Cannabis Reform bill in the Maryland House of Delegates and are responsible for shepherding it through the legislative straits were both opponents of legalizing the recreational use of marijuana.
Nevertheless, Del. C.T. Wilson (D-Charles), chair of the Economic Matters Committee, and Del. Vanessa Atterbeary (D-Howard), chair of Ways and Means, have dutifully bent to the will of the voters, who overwhelmingly approved legalization at the polls in November.
Before a reporter could finish a question Friday about the irony that the legislature is dependent on two people who, Wilson interjected, “That don’t like weed?”
“We believe in the concept of making it safer for Marylanders, of taking it out of the criminal stream of commerce,” he said. “Neither Delegate Atterbeary or I are consumers, but we do believe in that concept, and I believe overall it’s worth it. Plus, we listen to our citizens and they voted for it.”
For his part, Wilson said he did not vote for the measure in November, but knew it was going to pass.
“I don’t support marijuana; I support the effort we’re trying to undertake here,” he said. “It’s our job to make it the best bill we can and make it as equitable as we can.”
Atterbeary, too, had her reservations about the legalization idea.
“Having spent seven years on Judiciary [Committee], I have to say I didn’t necessarily support recreational use,” Atterbeary said at an impromptu briefing with reporters after the House session Friday.
House Economic Matters Committee Chair C.T. Wilson (D-Charles) and Ways and Means Committee Chair Vanessa Atterbeary (D-Howard) talk to reporters Friday about newly-introduced legislation to create a recreational cannabis industry in Maryland. (Maryland Matters/William Zorzi)
“But one of the things that was incredibly important to me was the equity piece,” she said, underscoring the importance of one of the key provisions of the bill.
The 88-page emergency bill, introduced Friday in both the House and Senate, will establish the state’s regulatory and taxation framework for the burgeoning adult-use marijuana industry, once the sale and recreational use of cannabis become legal July 1, as per the measure approved by voters. The House bill will be heard in Economic Matters, before Wilson.
On the Senate side, the bill was sponsored by Sen. Brian J. Feldman (D-Montgomery), chair of the Education, Energy and the Environment Committee, and Sen. Antonio L. Hayes (D-Baltimore City), a member of the Finance Committee. It was sent to Finance and the Budget and Taxation Committee for consideration.
“I feel very good about the bill. I think it has a chance to be a national model,” said Senate President Bill Ferguson (D-Baltimore City).
“It’s a complex topic; there are a lot of different pieces,” Ferguson said. “No state has gotten it right, and so what I do believe we’ve done effectively here is put us on the path to, one, protect public health and having a regulated marketplace, where we have a real regulatory framework to ensure that the product that is being sold on the street is safe, and, two, open up and expand the marketplace in an equitable way.”
Wilson also said he did not view the legislation as the big moneymaker for the state that many people believed it would be, as a result of the taxes that could be placed on the sale of the cannabis.
“Not everything we do needs to make money,” he said. “If we do it right, we might lose a little money the first time, but we’ll save a lot of lives, we’ll keep a lot of people out of jail. That’s worth way more than any taxes we could collect.”
Wilson said he understands that the cost of cannabis should not be more than what is available on the street, or it defeats the purpose of the state’s offering a safer alternative.
Strong Majorities Of Texans Support Medical And Recreational Marijuana Legalization, Including Most Republicans, New Poll Finds
Published 22 hours ago on February 2, 2023
Four out of five Texans support legalizing medical cannabis and decriminalizing possession of marijuana—and a strong majority across party lines also backs broader recreational legalization—according to a new poll.
The poll from YouGov and the University of Houston asked respondents about a wide range of legislative issues, including cannabis reform.
It found that 82 percent favor medical marijuana legalization, 81 percent back making simple possession punishable by a citation similar to a traffic ticket and 67 percent support legalizing cannabis for adult use.
For the medical marijuana question, that majority includes 93 percent of Democrats, 79 percent of independents and 73 percent of Republicans.
With respect to decriminalization, the policy is supported by 88 percent of Democrats, 77 percent of Republicans and 73 percent of independents.
Adult-use legalization similarly enjoys majority support regardless of party affiliation, with 80 percent of Democrats, 66 percent of independents and 55 percent of Republicans saying that favor the reform.
Via University of Houston.
The survey further asked respondents about which policy they’d prefer to see the legislature enact, and the majority (54 percent) said that they wanted marijuana to be legal for medical and recreational purposes.
Another 28 percent said that cannabis should only be made legal for medical use, while 18 percent said that they favor the status quo of criminalization.
Democrats and independents were the most likely to say that marijuana should be legalized across the board, at 63 percent for both. A minority of Republicans (38 percent) said the same, with more saying they’d prefer a medical-only system.
https://www.marijuanamoment.net/strong-majorities-of-texans-support-medical-and-recreational-marijuana-legalization-including-most-republicans-new-poll-finds/
Republican Congressman Reintroduces Bill To Move Cannabis to Schedule III
The Marijuana 1-to-3 Act would move cannabis to schedule III which would have several consequences.
BY
BENJAMIN M. ADAMS
FEBRUARY 2, 2023
As many advocates are pushing for decriminalization and completely descheduling cannabis at the federal level, one Republican congressman is pushing to simply downgrade cannabis from schedule I to schedule III, which would allow for research to move forward at a faster pace and provide several other perks.
Rep. Greg Steube (R-Florida) reintroduced a bill as H.R. 610 or the Marijuana 1-to-3 Act on Jan. 27, about four years after filing a similar bill previously, along with seven other bills, according to a press release.
The bill would direct the Attorney General of the United States to amend the Controlled Substances Act (CSA) to move cannabis from schedule I to schedule III of the Act—within 60 days of the bill’s enactment.
The bill doesn’t go as far as others that would end the federal prohibition of cannabis via decriminalization or other routes. However, the bill would protect federal employees who consume cannabis, as only Schedule I or II substances are prohibited. It would also free cannabis businesses affected by Tax Code 280E, and make research a lot more feasible.
Nice Close UP 33.3% today!! Up 55% for the Week!!!
The New AMA Study could help to get the Fed Legalization Passed
This study could help get Cannabis rescheduled from Class 1 to a Class 3 as a minimum.
Also the Safe Banking reform could get passed with AMA support.
Finally we may start to see a broader more to complete Federal Legalization of Cannabis this year!!
Cannabis stocks UP on AMA Report!!
This is HUGE, HUGE, HUGE!!!
"American Medical Association study shows, Marijuana can be an effective substitute for opioids for long-term users."
Positive American Medical Association report on medical marijuana.
Positive NEWS on AMA favoring marijuana legalization!!
There's more evidence now favoring medical marijuana legalization.
But medical marijuana is already legal in most states.
Investors in marijuana stocks such as SNDL (SNDL 4.94%), Aurora Cannabis (ACB 5.50%), and Tilray (TLRY 4.50%), are having a good day Thursday -- and not just because the Federal Reserve decided to only raise interest rates 0.25% yesterday. On top of that good news, you see, there's a new report by the American Medical Association (AMA) that argues medical marijuana may be at least part of the solution to solving America's opioid crisis.
And hearing that, investors are bidding up shares of SNDL by 4.7% today (through 11:10 a.m. ET), and delivering gains of 5.5% apiece to both Aurora Cannabis and Tilray investors.
So what is it about the AMA report that may be getting investors excited?
As Marijuana Moment reports, the AMA surveyed 8,165 patients currently using opioid drugs to treat chronic pain, who enrolled in a program to add cannabis to their pain treatment program. On average, the study showed that such patients were able to cut their consumption of potentially addictive opioids by anywhere from 47% to 51% after taking cannabis for eight months. (Note that this is now the second such study that's been backed by the AMA in less than a month, adding credibility to the conclusions.)
The effect was not immediate. Perhaps the most interesting data from the AMA study (interesting to marijuana investors at least), was the fact that patients seemed to need to get used to using marijuana instead of opioids for the full effects to manifest. Patients who used cannabis for less than 30 days were only able to cut their opioid consumption by between 4% and 14%.
2m taken out at ASK .0008, up 33% !!!
Still way, way too cheap! Nice Buy!!
Bottom is IN, going higher!!
2M .0008 HIT, now BID Building, 7M at .0007, Going Higher!!!
She is getting ready to RUN here, watch what happens, it is just too low, should be at least .003 to .005 todays value
8's are UP, LOL
Lets see if any sellers are still hanging around. Usually a High Volume Flush, 100M shares recently with 50% haircut will do the trick.
Schumer, Booker And Other Senators To Meet And Discuss Marijuana Legislation
Senate Sources Say
Published 21 hours ago on February 1, 2023
Senate Majority Leader Chuck Schumer (D-NY) and several other key Democratic senators are meeting Wednesday afternoon to discuss marijuana legislation, two Senate sources have confirmed to Marijuana Moment.
Advocates and stakeholders have been closely watching for any cannabis developments after efforts to pass modest reforms stalled out in the last Congress. Now the discussions are heating back up under different political dynamics, with Republicans in control of the House.
Schumer will be meeting with Sens. Cory Booker (D-NJ), Jeff Merkley (D-OR) and Jacky Rosen (D-NV), along with Senate Banking Committee
Chairman Sherrod Brown (D-OH), as Punchbowl News first reported.
Senate Finance Committee Chairman Ron Wyden (D-OR) was also invited, but an aide told Marijuana Moment that he had an “an unavoidable scheduling conflict” so would be sending a senior staffer in his place.
It remains to be seen whether the senators will be discussing any particular bills or cannabis-related issues, but it seems likely that they’ll pick up where they left off last session, with a focus on the so-called SAFE Plus package of marijuana banking and expungements legislation.
Compare GGII to PVSP - 55B shares, .0014, Mkt Cap $76Million, LOL
Just to show how insane the pinks are in valuing companies.
These guys have 55 BILLION shares outstanding, PVSP has 5 Billion
PVSP price is .0006, their price is .0014, it was 2 cents recently with Market Cap of $700 MILLION,, almost 1 BILLION, LOL
PVSP revenue $20 to 30 Million, their revenue $150k qtr, $600k a year.
Audited Financial PVSP late March early April
Management estimates the Audited Financials will be completed in a few weeks!!
Last Trades were BUYS filled by MM .00065, up 8.33% LOL
Going Higher!!
GOP cannabis rescheduling bill in Congress
This is BIG, the GOP is now behind rescheduling from Schedule 1 to Schedule III. This would open the gates for legalization at Federal level.
(Newsletter: February 1, 2023)
Published 4 hours ago on February 1, 2023
A GOP congressman has refiled a bill to move marijuana from Schedule I to the less restrictive Schedule III under federal law.
Rep. Greg Steube (R-FL) introduced the proposal on Friday. This is the third session in a row that he’s pushed for the modest reform, titled the “Marijuana 1-to-3 Act.”
https://www.marijuanamoment.net/gop-congressman-files-marijuana-rescheduling-bill-amid-ongoing-biden-administration-review/The two-page bill states that “the Attorney General of the United States shall, by order not later than 60 days after the date of enactment of this section, transfer marijuana…from schedule I of such Act to schedule III of such Act.”
Advocates are strongly pushing for removing cannabis from the Controlled Substances Act (CSA) altogether, but the congressman has argued that rescheduling could be an interim move to promote research into the plant and its components.
“As marijuana is legalized for medical and recreational use across the United States, it is important that we study the effects of the substance and the potential impacts it can have on various populations,” he said in 2019. “By rescheduling marijuana from a schedule I controlled substance to a schedule III controlled substance, the opportunities for research and study are drastically expanded.”
Sentiment never been worst for Cannabis Sector: Perfect Time to BUY!!!!!
Many speculators, traders, investors are burned out on waiting for Federal Legalization of Cannabis and have moved on, which is great for the long term investors that remain focused on the enormous potential for the Cannabis Market. Market value in 2022 was $17.8 Billion and Forecast to be over $134 Billion by 2030.
Report Overview
The global legal cannabis market size was valued at USD 17.8 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 25.3% from 2022 to 2030. The increasing rate of legalization of cannabis and acceptance of its use in the medical field are the key factors due to which the market is expected to boom. Cannabis has long been used for medicinal purposes but not as the first line of treatment. Research surrounding the use of cannabis for its medicinal properties has led to it being used for various indications. Cannabis has been found to be greatly effective in its ability as a therapeutic for chronic pain and in treating nausea caused due to chemotherapy. It is still classified as a Schedule I drug by the U.S. Drug Enforcement Administration (DEA), in spite of which it has been legalized in more than two-thirds of the states.
IMO in will be in the 1$ Trillion Wellness Business with KRTL Biotech
Hello $PVSP shareholders: $PVSP is executing multiple agreements to (1) continue development of its partnership with Freedom Cannabis, (2) a strategic wellness application and (3) expanding its Washington State based extraction capacity. Stay tuned!
1:26 PM · May 23, 2022
Pervasip and KRTL Biotech collectively referred to as the “Parties”, building on years of development, combined with a network of world-renowned stakeholders in the wellness space, announce the development of the Artizen Wellness joint venture to bring high quality wellness and nutritional foods products to market. Using proprietary formulations targeting mood, mental health and various ailments, Artizen Wellness will use unique low-THC cannabinoids (CBD/CBG/other), terpenes and well-known plant extracts to develop a range of products for worldwide distribution.
According to consulting firm McKinsey & Co. April 2021 Global Wellness Market survey, reconfirmed in 2022, consumers globally are spending approximately $1 trillion on wellness products. Natural, clean products are the #1 rising trend with 41 percent over 21 percent choosing natural supplements over more effective ones, a welcome trend that supports Artizen Wellness’ relentless focus on clean, natural compounds backed by peer reviewed research and proven efficacy.
Pervasip has commenced evaluation of potential targets for acquisition upon completion of the Artizen spin-off.
"The Company is working with its auditors to complete the required financial audits, including one for Pervasip on a consolidated basis and another for Artizen on a consolidated basis (without Pervasip). Once complete, a Form 10 Registration Statement will be filed with the SEC for Artizen to initiate the spin-off process. Additional information regarding the status and timing of the transaction and the various required regulatory and other approvals will be provided as it becomes available. Pervasip has commenced evaluation of potential targets for acquisition upon completion of the Artizen spin-off."
Audit expected to be completed late March 2023, to early April 2023
HUGE: House Republican reintroduces bill to reschedule marijuana
By MJBizDaily Staff
January 31, 2023 - Updated January 31, 2023
A Republican U.S. representative from Florida reintroduced legislation that would reclassify marijuana under federal law.
The bill would greatly aid both marijuana businesses suffering under federal tax burdens as well as would-be researchers.
Rep. Greg Steube, who began his third term this month, reintroduced what he calls the “Marijuana 1-to-3 Act,” his office announced in a recent news release.
The bill would move marijuana from Schedule 1 in the Controlled Substances Act to Schedule 3.
Such a move would have major ramifications for cannabis researchers as well as legal marijuana businesses.
Steube’s measure comes almost four months after President Joe Biden called on the U.S. attorney general and the secretary of the Department of Health and Human Services to begin the process of reviewing marijuana scheduling under federal law.
Marijuana companies currently barred from claiming many normal business expenses on their federal tax returns would see that prohibition lifted if Steube’s bill were to become law.
It’s the third time in his three terms that Steube has tried to push such legislation.
His previous efforts, in 2019 and 2021, died after the bill did not receive a hearing under Congress’ then-Democratic majority.
It’s unclear whether Steube’s bill will have better luck in a Republican-controlled Congress under Republican House Speaker Kevin McCarthy of California.
Steube’s office did not immediately respond to a request for comment from MJBizDaily.
A reliable congressional advocate for cannabis, Steube is one of a growing number of House Republicans pushing federal marijuana reform.
He also is one of the 100 Republicans who voted in support of the SAFE Banking Act.
Last Trade 13:56, 83k shares .00065
Still don't think the conversions are over? LOL
They are done, stick a fork in them, LOL
Senator Confirms ‘SAFE Plus’ Marijuana Banking Deal Includes Gun Rights And Expungements, Saying It ‘Must Pass’ In 2023
Published 1 month ago on December 21, 2022
As congressional lawmakers lament the failure to get marijuana banking legislation attached to a large-scale spending bill, one senator is giving details about what bipartisan negotiations over the so-called SAFE Plus package entailed, including “important expungement and second amendment rights provisions.”
While it has been previously reported that gun rights were included in the package in order to get buy-in from conservatives as lawmakers pushed to produce passable legislation during the lame duck session, the new comments from Sen. Jeff Merkley (D-OR) appear to be the first on-the-record confirmation from a lawmaker on the issue.
Even though key legislators agreed on the framework of the cannabis reform deal, they couldn’t push past opposition from Republican leaders who refused to allow it to be included in large-scale legislation. But Merkley, a prime sponsor of the Secure and Fair Enforcement (SAFE) Banking Act, says that “we’ve made so much progress on forging bipartisan consensus,” and he “won’t rest until we get it done.”
https://www.marijuanamoment.net/senator-confirms-safe-plus-marijuana-banking-deal-includes-gun-rights-and-expungements-saying-it-must-pass-in-2023/
Fed may be DONE with increasing rates !!!!
Tomorrow Fed announcement on Interest Rates will Jolt Markets HIGHER!
White House Defers To Congress On Marijuana Banking Reform
Published 18 hours ago on January 30, 2023
The White House says that Congress is leading the charge for marijuana banking reform—and the Biden administration does not currently have any plans to announce executive action on the issue.
At a press briefing last week, White House Press Secretary Karine Jean-Pierre was asked whether President Joe Biden intends to administratively resolve the banking issue for state-legal cannabis businesses, many of which operate on a largely cash-only basis and have been targets of crime under federal prohibition.
“I don’t have any new policy announcements to make from here,” Jean-Pierre said.
“As you know, this is something that Congress is working on,” the press secretary said in response to the question from NJ.com’s Jonathan Salant. “We understand that there’s interest in legislation and action—but I would refer you to Congress because, again, this is again what they’re working on.”
Acquire Assets adding $12M Revenue in 2023
From Shareholder Letter in December
We developed strategic relationships to diversify into the regional concentrates market and negotiated to acquire assets capable of adding $12 million in annualized revenue in Washington by the end of next year.
We identified a series of exciting expansion opportunities, including licensed wholesale and retail operations that we hope to acquire to establish ourselves as a vertically integrated multi-state operator (“MSO”).
Nice Close, 6's are GONE!! 7's are UP!! +20%
She looks about read to RUN, only time will tell but anything under .003 is just a no brainer!!
Market Cap $1.8M , LOL, LOL Impossible!
A company that generates of $20M in revenue and is cash flow positive or very close, with NO DEBT on Spin Off is worth a lot more than $1.8M
PVSP was valued $50M before Artizen and only had revenue of $450k annually most some on line advertising site.
GGII was valued at over 3 cents with 20 BILLION shares outstanding, over $600 Million market cap, with revenue of $1.4M QTR, or $5M revenue annually.
Bottom line Pink markets are completely unreliable in assessing accurate value of companies via share price, as liquidity is so poor and manipulation so wide spread.
Management is saying, Cannabis Assets are Dirt Cheap!!!
IMO we can acquire all kinds of assets in the Cannabis space for a few pennies on the Dollar. We may be able to acquire some great assets with a little fix term financing that is shareholder friendly, that will allow us to rapid expand our revenue and profitability picture.
Virginia Lawmakers Approve Bills On Marijuana Sales And 280E Tax Reform
Big NEWS, States are reforming 280E themselves!!
Published 16 mins ago on January 30, 2023By Kyle Jaeger
Virginia lawmakers on Friday advanced bills to start adult-use marijuana sales and allow cannabis businesses to make certain tax deductions at the state level while they’re barred from doing so federally under the Internal Revenue Services (IRS) code known as 280E.
The 280E bill passed the Senate unanimously in a 40-0 vote, carried by Sen Adam Ebbin (D). The House of Delegates companion version from Del. Jeffrey Campbell (R) moved through an Appropriations subcommittee in a 7-1 vote and now heads to the full panel for consideration.
The legislation seeks to decouple Virginia’s marijuana industry from the federal tax code, as lawmakers in several states like New Jersey, New York and Pennsylvania have moved to do. State medical and recreational cannabis businesses would be able to take deductions at the state level that they’re currently barred from doing federally under IRS’s 280E.
Separately, in the Democratic-controlled Senate, the Rehabilitation and Social Services Committee voted 9-6 to refer an adult-use marijuana sales bill, also from Ebbin, to the Finance and Appropriations Committee.
There have been open questions about how the state legislature would address cannabis commerce for adults in the 2023 session after lawmakers approved a bill in 2021 legalizing marijuana possession for people 21 and older. That legislation included sales provisions but they were subject to reenactment, and lawmakers in 2022 did not act on the issue under the new Republican governor and GOP-controlled House of Delegates.
The House has since been a sticking point for advocates, with legislators largely divided on how to proceed with a possible commercial market. The legislation that passed a Senate committee on Friday would allow recreational cannabis sales to begin on January 1, 2024.
BIDS are stacking PreMarket already!!
3M plus on BID already, very unusual as many brokers don't allow pink pre market trades.
Report: Cannabis Market Could Grow to $48B by 2027
A new report by Emergen Research suggests the global cannabis market could grow to $48.29 billion by 2027, representing a CAGR of 24.6%. Emergen said in 2019, the market was worth $8.26 billion.
“Proven medical effects of cannabis, legalization, active research genetic development and modification of the plant, and developments in cannabis intellectual property rights have all been recognized as cannabis market drivers. The market is dominated by North America. Because cannabis is widely utilized for therapeutic purposes in the United States, the industry has evolved and matured tremendously. Cannabis, as a psychoactive drug,
The report notes that the North American duo of the U.S. and Canada currently “dominates” the market. Cannabis is legal in Canada and individual U.S. states and territories have legalized cannabis for either adult or medical use. Emergen suggests that the Asia Pacific region will account for the fastest growth through 2027 but notes that many European nations have begun to liberalize their cannabis laws; including Germany, which legalized medical cannabis in 2017, and France which legalized medical cannabis use in 2013 and five years later reduced penalties for possession.
Italy also legalized medical cannabis use in 2013 and has effectively decriminalized personal possession, while the United Kingdom legalized some medical cannabis products in 2018.
Emergen notes that industry market trends include the infusion of both alcoholic and non-alcoholic beverages and “tremendous demand from the therapeutic market.”
Study: Cannabis Legalization Does Not Lead to Increased Use of Other Drugs
Thu / Jan 26th by TG Branfalt
A new report found cannabis legalization does not lead to an increase in substance use disorders or the increased use of illicit drugs.
“Recreational legalization was associated with increased cannabis use and decreased [alcohol use disorder] symptoms but was not associated with other maladaptations. … Moreover, vulnerabilities to cannabis use were not exacerbated by the legal cannabis environment.” — “Recreational cannabis legalization has had limited effects on a wide range of adult psychiatric and psychosocial outcomes,” Jan. 5, 2023, Psychological Medicine
https://www.ganjapreneur.com/study-cannabis-legalization-does-not-lead-to-increased-use-of-other-drugs/
"100M shares on fully diluted basis" Issued 15M ?
My guess is maybe 15M shares will be the issued outstanding shares and the 85% will be restricted just like now with PVSP, same ratio's.
"Artizen will have 100,000,000 common shares outstanding on a fully diluted basis upon completion of the transaction, with no convertible debt or other securities."
The Reversal will be Wicked!!
Watch the chase begin any day now.
PVSP acquisition news would do the trick.
That is exactly what "Capitulation" looks like! LOL
50% sell off is classic sign that a New Bottom is forming!! 95M shares traded, what $50k total?
So one person with 35m shares dumps them, so what there is your massive sell off, LOL
Market Cap of PVSP including Artizen is $1.8M which is laughable for a company generating over $20M Revenue annually, and projected to be over $30M end 2023.
PVSP ran to over 1 cent before Artizen was included, and that was with only $450 in annual revenue, LOL